These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 2936622
1. gp 140, the C3d/EBV receptor (CR2), is phosphorylated upon in vitro activation of human peripheral B lymphocytes. Barel M, Vazquez A, Charriaut C, Aufredou MT, Galanaud P, Frade R. FEBS Lett; 1986 Mar 03; 197(1-2):353-6. PubMed ID: 2936622 [Abstract] [Full Text] [Related]
2. Structure and functions of gp 140, the C3d/EBV receptor (CR2) of human B lymphocytes. Frade R. Mol Immunol; 1986 Nov 03; 23(11):1249-53. PubMed ID: 2950318 [Abstract] [Full Text] [Related]
3. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. Nemerow GR, McNaughton ME, Cooper NR. J Immunol; 1985 Nov 03; 135(5):3068-73. PubMed ID: 2995485 [Abstract] [Full Text] [Related]
4. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR. J Virol; 1987 May 03; 61(5):1416-20. PubMed ID: 3033269 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways. Bouillie S, Barel M, Drane P, Cassinat B, Balbo M, Holers VM, Frade R. Eur J Immunol; 1995 Sep 03; 25(9):2661-7. PubMed ID: 7589142 [Abstract] [Full Text] [Related]
6. gp140, the EBV/C3d receptor (CR2) of human B lymphocytes, is involved in cell-free phosphorylation of p120, a nuclear ribonucleoprotein. Delcayre AX, Fiandino A, Barel M, Frade R. Eur J Immunol; 1987 Dec 03; 17(12):1827-33. PubMed ID: 2446881 [Abstract] [Full Text] [Related]
7. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d. Hutt-Fletcher LM, Fowler E, Lambris JD, Feighny RJ, Simmons JG, Ross GD. J Immunol; 1983 Mar 03; 130(3):1309-12. PubMed ID: 6218205 [Abstract] [Full Text] [Related]
9. Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase. Barel M, Le Romancer M, Frade R. J Immunol; 2001 Mar 01; 166(5):3167-73. PubMed ID: 11207269 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Tanner J, Weis J, Fearon D, Whang Y, Kieff E. Cell; 1987 Jul 17; 50(2):203-13. PubMed ID: 3036369 [Abstract] [Full Text] [Related]
11. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction. Masucci MG, Szigeti R, Ernberg I, Hu CP, Torsteinsdottir S, Frade R, Klein E. Eur J Immunol; 1987 Jun 17; 17(6):815-20. PubMed ID: 3036539 [Abstract] [Full Text] [Related]
12. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). Nemerow GR, Wolfert R, McNaughton ME, Cooper NR. J Virol; 1985 Aug 17; 55(2):347-51. PubMed ID: 2410629 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT. Proc Natl Acad Sci U S A; 1984 Jul 17; 81(14):4510-4. PubMed ID: 6087328 [Abstract] [Full Text] [Related]
14. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor. Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W. EMBO J; 1991 Apr 17; 10(4):919-26. PubMed ID: 1849076 [Abstract] [Full Text] [Related]
15. Structure and signalling functions of C3 receptors on human B cells. Frade R. Semin Immunol; 1990 Mar 17; 2(2):159-64. PubMed ID: 2151800 [Abstract] [Full Text] [Related]
16. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system. Tedder TF, Goldmacher VS, Lambert JM, Schlossman SF. J Immunol; 1986 Aug 15; 137(4):1387-91. PubMed ID: 3016095 [Abstract] [Full Text] [Related]
17. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT. J Exp Med; 1988 Mar 01; 167(3):1047-66. PubMed ID: 2832506 [Abstract] [Full Text] [Related]
18. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor. Pernegger G, Schulz TF, Hosp M, Myones BL, Petzer AL, Eigentler A, Böck G, Wick G, Dierich MP. Immunology; 1988 Oct 01; 65(2):237-41. PubMed ID: 2461345 [Abstract] [Full Text] [Related]
19. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21). Esparza I, Becherer JD, Alsenz J, De la Hera A, Lao Z, Tsoukas CD, Lambris JD. Eur J Immunol; 1991 Nov 01; 21(11):2829-38. PubMed ID: 1834472 [Abstract] [Full Text] [Related]
20. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions. Mold C, Cooper NR, Nemerow GR. J Immunol; 1986 Jun 01; 136(11):4140-5. PubMed ID: 3009615 [Abstract] [Full Text] [Related] Page: [Next] [New Search]